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Summary A retrospective analysis of 321 gastric cancer patients was made to assess the prognostic value of
TNM classification, tumour differentiation, Lauren classification, proliferative rate, inflammatory reaction and
tumour invasion in vascular or neural structures of the gastric wall. The TNM classification showed the
strongest correlation with survival in univariate and multivariate analyses (P<0.0001). The invasion in
lymphatic or vascular system and Lauren classification were also independent prognosticators in multivariate
analysis (P<0.05). In univariate analysis, the WHO-grade, the size and the location of the tumour and
perinueral invasion were significant prognostic factors (P<0.01), as were the infiltration of lymphocytes and
plasma cells in the tumour (P<0.05). On the other hand, the mitotic indices reflecting the proliferative activity
of the tumour cells showed no significant correlation with the prognosis. The results indicate that the
prognostic power of the TNM classification can be further increased by assessment of the above special
histological features in gastric cancer.
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Prognosis of patients with gastric adenocarcinoma remains
poor despite sophisticated diagnostic and operative techni-
ques. Unfortunately, the tumour is often too widely spread at
diagnosis to be treated radically with gastrectomy. The
Japanese experience with gastrectomy including extended
radical lymphadenectomy is encouraging, but in Western
countries the results of this new surgical technique is still
controversial (Siewert et al, 1993; Lisborg et al., 1994;
Bonenkamp et al., 1995). The policy of adjuvant therapy in
gastric cancer is not uniform, since the results have usually
been unsatisfactory or of limited value (Hermans et al., 1993;
Douglass, 1994). More detailed information about the
prognostic factors in gastric carcinoma is needed to assist
the selection of the right patients for extended surgical
procedures and for trials of adjuvant chemotherapy.
Clinical features including the size and location of the
tumour have been used as prognostic factors in gastric cancer
(Hermanek, 1986; Maruyama, 1987). The radicality of the
operation as measured by tumour-free margins and the extent
of lymphadenectomy have been shown to be of definitive
prognostic value (Hermanek, 1986; Siewert et al., 1993), as
has the age of the patient (Haugstvedt et al., 1993; Lisborg et
al., 1994). Thje most powerful prognostic factors in gastric
cancer seem to be the depth of tumour invasion in the gastric
wall, the status of local lymph nodes and the presence of
distant metastases (Maruyama, 1987; Gabbert et al., 1991;
Yu et al., 1995). This information is also included in the
TNM classification which is the most widely used prognostic
parameter in gastric cancer. The size of the tumour and
invasion to vascular and lymphatic system are related to the
TNM classification and thus affect survival (Maruyama,
1987; Gabbert et al., 1991). Tumour differentiation (WHO
grade) is also used as a prognostic factor (Lisborg et al.,
1994; Yu et al., 1995). The histological classification of
Lauren, which is based on the growth pattern and
morphology of the tumour, has shown its prognostic value
in several studies (Lauren, 1965; Davessar et al., 1990; Yu et
al., 1995). The rate of tumour growth has traditionally been
estimated by the amount of mitoses in the tumour tissue, but
little attention has been paid to mitotic frequency in gastric
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cancer (Paile, 1971; Tabuchi, 1986; Korenaga et al., 1990).
Similarly, the role of inflammatory cell reaction in gastric
cancer is still poorly understood, although it seems to be
associated with patient survival (Schmitz-Moorman et al.,
1992; Yu et al., 1995).
The present study was designed to test the previously
recognised, simple and easily evaluable histological factors
that could be used as prognostic predictors in combination
with the TNM classification. We were specially interested in
examining the prognostic value of mitotic indices in gastric
cancer because of their powerful prognostic significance in
several other human malignancies (Haapasalo et al., 1989;
Lipponen et al., 1990; Aaltomaa et al., 1992; Vesalainen et
al., 1995).
Materials and methods
Patients
This retrospective study was based on the follow-up data of
321 patients diagnosed and treated for gastric cancer at
Kuopio University Hospital between 1976 and 1988 and
followed up until 1993. From the consecutive series of all
gastric adenocarcinomas (425 patients) these 321 cases were
selected, because sufficient samples of the primary tumour
were available in these cases. Patient records were reviewed
and the pertinent clinical data of the patients are shown in
Table I.
The location and size of the tumour as well as the status of
the regional lymph nodes and other intra-abdominal organs
were registered as described on gastroscopy, at operation or
in examination of the resected stomach. The follow-up data
including the time and location of metastases or other
recurrence of the tumour were collected from the patient
records, and in some cases, by an inquiry sent to the patient.
The causes of death were obtained from the patient records
and from the files of the Finnish Cancer Registry and
General Statistical Office in Finland.
Histological methods
The tumour samples were routinely fixed in 10% buffered
formalin and embedded in paraffin. Several original sections
from each of the primary tumours were re-examined and the
most representative tissue block was selected, cut at 5 ,umthickness and stained in haematoxylin and eosin (H&E).
These original and new sections were examined by two
experienced histopathologists (VMK and SM) simultaneously
while being unaware of the clinical data. The tumours were
classified according to Lauren as diffuse, intestinal, mixed or
unclassified (Lauren, 1965). All tumours except those of the
diffuse type were graded as well differentiated (I), moderately
differentiated (II) or poorly differentiated (III). The depth of
tumour invasion was registered in all samples which
contained the full thickness of gastric wall. Similarly, tumour
invasion into the walls of veins, arteries and lymphatics or
into the perineural space was registered in this new
representative H&E section and graded as absent, weak or
extensive (the latter groups were later combined to form one
group of positive invasion). The infiltration of lymphocytes
and plasma cells (TIL, tissue-infiltrating lymphocytes) was
estimated avoiding ulcerated or necrotic areas and graded as
weak, moderate or strong. In some small endoscopic samples,
we were not able to confirm all histological variables. The
histological features are summarised in Table II.
The new representative H&E section was used in counting
the mitotic figures. After reviewing this section, a well-
preserved and highly cellular area near to the tumour margin
was selected, because the marginal areas are considered to be
rich in mitoses. The mitotic figures were counted in ten
consecutive high-power microscopic fields with a magnifica-
tion of 400 (field diameter 400 gm). Only the cells with
detectable chromosomes were accepted as mitotic figures. The
fraction of neoplastic cells (in proportion to all cells) was
stimultaneously estimated in each microscope field, and mean
fraction in all fields was expressed in percentage as tumour
'volume'. Two mitotic indices, MAI (mitotic activity index)
and M/V (volume-corrected mitotic index) were determined
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as described earlier by Haapasalo et al. (1989). MAI
expresses the number of mitotic figures per one square
millimetre of the sample, and M/V expresses the number of
mitotic figures per one square millimetre of neoplastic tissue.
Table II Histological features analysed
Factor Codes Number %
Lauren type Diffuse 141 44
(n =321) Intestinal 140 44
Mixed 26 8
Unclassified 14 4
WHO grade Grade I 39 22
(n= 177) Grade II 89 47
Grade III 49 31
Level of invasion Mucosa 14 5
(n=257) Submucosa 14 5
Muscle 43 17
Serosa 186 72
Vascular invasion Negative 237 93
(n=255) Positive 18 7
Lymphatic invasion Negative 138 54
(n =256) Positive 118 46
Perineural invasion Negative 140 55
(n =256) Positive 116 45
Lymphoplasmacytic Weak 161 62
infiltration Moderate 78 30
(n=258) Strong 19 7
Table I Clinical characteristics of the patients (n = 321)
Sex
Male
Female
Age in years (s.d., range)
Follow-up time in years
Size of the tumour
<2 cm
2-5 cm
5-10 cm
>10 cm
Unknown
Depth of invasion
pTI
pT2
pT3
pT4
TX
Nodal status
pNO
pNl
pN2
NX
Metastases
MO
Ml
M2
Location
Proximal third
Middle third
Distal third
>one third
Operation
Total gastrectomy
Subtotal gastrectomy
Gastric resection
Exploration or bypass
No operation
179
142
67.6
10.2
22
65
79
79
76
35
49
153
51
33
108
119
28
66
226
65
30
58
46
147
68
118
88
50
32
33
(12.3/22.9-93.0)
(3.9/4.2-17.9)
7%
20%
25%
25%
24%
11%
15%
48%
16%
10%
34%
37%
9%
21%
70%
20%
9%
18%
14%
46%
21%
37%
27%
16%
10%
10%
Table III Mitotic activity index (MAI) and volume-corrected
mitotic index (M/V) as related to Lauren classification (P<0.0001)
Mean MAI (s.d.) Mean M/V (s.d.)
All patients (n=321) 27.4 (23.0) 37.1 (27.9)
Lauren class
Diffuse 18.3 (15.0) 24.8 (18.2)
Intestinal 34.0 (25.8) 48.0 (31.1)
Mixed 30.0 (25.3) 40.5 (29.2)
Table IV Histological features related to pT- and pN-categories
Variable Ti T2 T3 T4 NO N-2
Lauren type
Diffuse 17 18 76 24 51 66
Intestinal 16 25 5 20 48 55
Mixed 2 4 15 3 7 15
P=NS P=NS
WHO grade
I 14 5 12 4 25 10
II 3 18 39 13 21 39
III 1 7 24 10 10 30
P<0.001 P<0.001
Vascular invasion
No 35 43 13 23 104 113
Yes 0 3 12 3 2 16
P=NS P<0.001
Lymphatic invasion
No 33 29 63 12 80 45
Yes 2 17 84 14 26 84
P<0.001 P<0.001
Perineural invasion
No 32 24 70 12 68 61
Yes 3 22 77 14 38 68
P<0.001 P=NS
TIL
Weak 18 21 97 22 64 80
Moderate 6 21 42 9 27 43
Strong 2 5 11 1 9 9
P=NS P=NS
NS, not significant; TIL, tissue-infiltrating lymphocytes and plasma
cells.Prognostic factors in gastric cancer
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The reproducibility of this latter method has been repeatedly
documented in different neoplasms (Haapasalo et al., 1989;
Lipponen et al., 1990). The values of the mitotic indices are
shown in Table III.
Statistical analysis
In basic statistical calculations, the SPSS-X program was
used in an IBM computer and the statistical tests used are
indicated in Results shown when appropriate. Frequency
distributions were tested by the chi-square test and Yate's
correction was applied when appropriate. The differences
between the means of continuous variables were tested by
analysis of variance. The univariate survival analysis (log-
rank analysis, SPSS-X) was based on the life-table method
with the statistics of Lee and Desu. Multivariate survival
analysis (Cox model) was done with the BMDP (2L) program
package in a stepwise manner and continuous variables were
used as absolute numbers in this analysis. Enter limit was
P<0.1 and removal limit was P<0.15.
Results
Of the 321 patients, 288 patients were operated on. The
primary tumour was removed with total or subtotal
gastrectomy or gastric resection in 256 cases (Table I). The
dissection of perigastric lymph nodes (NI) was routinely
performed in connection with gastrectomy, but splenectomy
was done in 38 cases only. The post-operative mortality
within 30 days was 11% (31/288). By the end of the follow-
up in 1993, 249 patients had died of gastric cancer, four
patients of other histologically confirmed cancer (leukaemia,
prostatic cancer, squamous-cell lung cancer and hepatocel-
lular cancer) and 18 patients of other causes, usually cardiac
or pulmonary diseases. Altogether, 50 patients were alive,
giving the overall 5 year survival of 23%.
The relations between histological features and TNM
classes are shown in Table IV. Lymphatic and perineural
invasion were more frequent in tumours of advanced stage
with nodal metastases, and these tumours were more often
pooly differentiated. No significant correlation was found
between Lauren classes and TNM stage. The density of
lymphocytes and plasma cells in the tumour was also
independent of the stage and any other histological feature.
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Figure 2 Survival rate according to lymphatic invasion. Neg,
negative; pos, positive. (n=255, P=0.000, X2=21.2).
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Figure 1 Survival rate according to the depth of tumour
invasion in gastric wall. A, mucosa; B, submucosa; C, muscle;
D, serosa. (n=256, P=0.000, X2=41.7).
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Figure 3 Survival rate according to the WHO grade. 1, well
differentiated; 2, moderately differentiated; 3, poorly differen-
tiated. (n= 176, P=0.001, X = 14.5).
0
2XMitotic indices showed a significant variation between
Lauren classes: MAI and M/V were higher in the intestinal
type than in the diffuse type (Table III). Mitoses were more
frequent in tumours with lymphatic invasion (P<0.05), but
not significantly related to other histological features.
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diffuse type of cancer, the volume-corrected mitotic index,
M/V, reached a statistical significance as a prognostic
predictor in univariate survival analysis (P=0.012). For
these patients, the 5 year survival was 35% in cases with low
mitotic activity, compared with 15% in cases with high
mitotic activity (other data not shown).
Survival analyses
The most important prognostic factors in univariate survival
analysis were the depth oftumour infiltration, the presence of
lymph node metastases or distant metastases, the size of the
primary tumour and tumour invasion in the lymphatics
(Figures 1 and 2, Table V). The WHO grade and vascular or
perineural invasion were also important prognosticators of
survival (Figures 3 to 5), as well as the lymphoplasmacytic
infiltration (Figure 6). Location of the tumour was found to
have prognostic significance, tumours in the middle or distal
parts ofthe stomach being more favourable than those situated
in the proximal third or in more than one third (Table V). The
histological type of Lauren was not a significant prognostic
factor in univariate analysis of all patients.
In order to get better accuracy in survival analysis, the
prognostic value ofthe clinical and histological variables ofour
studywas tested in asubgroup ofoperatedpatients (n =256). In
these cases, the primary tumour had been resected (total or
subtotal gastrectomy or gastric resection of two thirds). The
operation was palliative in 43 cases because of distant
mestastases. The results of survival analysis in this subgroup
were comparable with the analysis of all patients, TNM stage
and tumour size having strongest impact on survival. In
addition, Lauren classification reached a statistical significance
as a prognostic factor, and the intestinal type of cancer was
shown to have more favourable prognosis than the diffuse or
mixed types ofcancer (Table VI).
The mitotic indices MAI and M/V were not related to
survival when all patients were analysed together. For more
detailed analysis, the operated patients were divided in two
groups according to the Lauren classification (intestinal
n=98, diffuse n = 124). In the intestinal type of cancer, the
mitotic activity did not affect survival. However, in the
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Figure 5 Survival rate according to vascular invasion. Neg,
negative; pos, positive. (n=254, P=0.005, X2 =79)
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Figure 4 Survival rate according to perineural invasion. Neg,
negative; pos, positive. (n =255, P= 0.000, X2 = 13.7).
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Figure 6 Survival rate according to the density of lymphoplas-
macytic infiltration in the tumour. 1, weak; 2, moderate; 3, strong
infiltration. (n=257, P=0.024, X2 =7.5).
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Table V Clinical and histological factors related to survival in
gastric cancer
5 year 10 year
No. of survival survival
Variable patients (%) (%)
Size of the tumour
>2 cm 22 95 85 P=0.0000
2-5 cm 65 40 30 X2=64.l
5-10 cm 78 20 10
>10 cm 79 10 10
Location
Proximal third 58 15 15 P=0.005
Middle third 46 35 20 x2= 12.9
Distal third 146 30 20
>one third 68 10 10
Depth of invasion
pTI 35 80 72 P=0.0000
pT2 48 45 25 %2=92.9
pT3 153 15 10
pT4 51 5 0
Nodal status
pNO 107 60 45 P =0.0000
pNI 119 10 5 X2 =71.3
pN2 28 0 0
Metastases
MO 225 30 25 P=0.0000
M1 65 0 0 x2= 59.1
Table VI Histological factors related to survival in patients
operated for gastric cancer (n =256)
S year 10 year
No. of survival survival
Variable patients (%) (%)
Lauren class
Diffuse 124 25 15 P=0.022
Intestinal 98 35 30 x2=7.62
Mixed 23 20 20
WHO grade
1 33 55 40 P=0.011
2 61 25 15 X2=8.93
3 34 25 20
Vascular invasion
Negative 231 30 25 P=0.003
Positive 18 5 0 %2=8.99
Lymphatic invasion
Negative 134 40 35 P=0.000
Positive 116 15 5 X2=25.6
Perineural invasion
Negative 134 40 35 P=0.000
Positive 116 15 10 %2= 17.8
TIL
Weak 150 25 20 P=0.051
Moderate 75 25 15 x2= 5.94
Strong 19 40 40
TIL, tissue-infiltrating lymphocytes and plasma cells.
Table VII The independent prognostic factors of gastric cancer in
multivariate survival analysis (n=219)
Variable ,B s.e. CI RR P-value
Depth of invasion 0.632 0.114 1.51-2.35 1.88 0.000
Nodal status 0.523 0.089 1.42-2.01 1.69 0.000
Vascular invasion 0.905 0.268 1.46-4.18 2.47 0.001
Lymphatic invasion 0.337 0.110 1.13-1.74 1.40 0.002
Lauren classification 0.304 0.127 0.58-0.95 0.74 0.017
,B, regression coefficient; s.e., standard error; CI, 95% confidence
interval ofratio ofrisk; RR, ratio ofrisk.
In multivariate survival analysis of the operated patients, all
histological factors were tested except the WHO grade,
because its inclusion would have excluded all diffuse-type
tumours. Of the 256 patients, 219 entered the Cox model. We
found the level of invasion, the presence of nodal metastasis,
the vascular and lymphatic invasion and the Lauren
classification to be independent prognosticators of survival
(Table VII). When the WHO grade was included in the
multivariate analysis of the patients with an intestinal type of
tumour (n= 110), it did not reach statistical significance as an
independent prognostic factor (P=0.10, other data not
shown).
Discussion
Among all prognostic factors in gastric cancer, the depth of
tumour invasion and the presence of lymph node metastasis
seem to be the most important factors in most studies
(Maruyama, 1987; Yu et al., 1995). In our univariate survival
analysis, the pT stage was the strongest prognostic factor but
the accuracy was improved by separating mucosal and
submucosal tumours from each other. The poorer survival
for patients with submucosal invasion is also reported by
others (Hermanek, 1986; Maruyama, 1987). Recently, in the
supplement of TNM classification in 1993, this difference has
been taken into account, and pT tumours are divided into
Tla (mucosal) and Tlb (submucosal) tumours (Hermanek
and Wittekind, 1995).
The tumour invasion to vessels and perineural space
offers an additional route for tumour spread outside the
gastric wall. The presence of vascular, lymphatic and neural
invasion are found to be related to TNM stage (Gabbert et
al., 1991; Tanaka et al., 1994; Mori et al., 1995). In this
study, the presence of lympatic invasion could predict lymph
node involvement (P=0.0000). However, the prognostic
value of lymphatic and vascular invasion is also shown
within pT and pN categories, different grades and
histological types (Gabbert et al., 1991). Lymphatic and
vascular invasion were significant and independent prog-
nostic predictors in multivariate (Okada et al., 1983) and in
univariate analysis (Lisborg et al., 1994).
The incidence of vascular invasion in gastric cancer varies
from 7.2% to 86%, which can be caused by different staining
methods and number of examined samples, and also different
criteria of vascular invasion (Noguchi, 1990; Gabbert et al.,
1991). In our series, the incidence of vascular invasion was
quite low (7%), because it was assessed in one representative
section only. It was, however, a significant and independent
prognostic factor in univariate and multivariate survival
analyses (RR 2.47).
The association between tumour location and disease
outcome has previously been recognised in several studies
(Lauren, 1965; Maruyama, 1987; Davessar et al., 1990). A
cancer in the proximal third (cardia and fundus) usually has
a more unfavourable prognosis than tumours in the middle
or distal third. This is probably owing to a more advanced
stage of the tumours in the former site, frequently in pT3 or
pT4 at the diagnosis (Hermanek, 1986; Davessar et al.,
1990). Furthermore, the extensive distribution of potentially
metastatic lymph nodes in advanced cancer of the proximal
third may explain the poorer prognosis (Noguchi et al.,
1989). In our study, survival rates of the tumours in the
middle or distal parts were almost twice as favourable as
those in the proximal third (5 year survival 30-35% vs 15%
respectively). The tumours in the distal third were more
often in early stage, e.g. all except one of the intramucosal
tumours were located in the antrum or pylorus.
In this cohort, Lauren classification was related to survival
only in the group of operated patients. This is comparable
with the results of Hermanek (1986) and Davessar et al.
(1990), who observed better survival rates for the intestinal
type in advanced gastric cancer treated with gastrectomy.
Interestingly, it has been reported that in pTl and pT2Prg-sdc facersUin e eamee
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carcinomas, the prognosis for the diffiise type is better than
for the intestinal type (Iriyama et al., 1993). The prognostic
potential of Lauren classification may be stage-related, which
could explain the disagreement between the results obtained
from variable materials.
Lymphoplasmacytic response around and in the tumour is
suggested to reflect tumour-host interaction and to be
associated with prognosis in gastric cancer (Davessar et al.,
1990; Schmitz-Moorman et al., 1992; Yu et al., 1995) and
other neoplasms (Lipponen et al., 1993). A dense infiltration
usually indicates a more favourable prognosis. The prog-
nostic power of the inflammatory cell reaction in gastric
cancer is independent ofthe histological type (Davessar et al.,
1990). In our study, we found no relation between the density
of lymphoplasmacytic infiltration and stage or any other
histological feature. However, the density oflymphocytes and
plasma cells was not an independent prognostic predictor in
multivariate analysis, despite its power in univariate analysis.
Two previous studies have revealed a negative correlation
between the mitotic count and the patient's prognosis (Paile,
1971; Tabuchi et al., 1986). Mitotic activity has been related
to DNA abnormalities and to a metastatic tendency in gastric
cancer (Korenaga et al., 1990). Detailed analyses of other
neoplasms (e.g. bladder and breast cancers) have established
the strong prognostic value for the mitotic indices, MAI and
M/V (Lipponen et al., 1990; Aaltomaa et al., 1992). However,
the present results suggest that the mitotic activity is of very
limited value as a prognostic predictor in gastric cancer. The
method of mitosis counting suffers from some limitations. In
several tumours included in this study, a significant variation
in the mitotic rates was noticed in different areas of the same
tumour. This was observed also by Concetti et al. (1981) and
Korenaga et al. (1995). The variation in mitotic rates reflects
intratumoral heterogeneity, which can reduce the reproduci-
bility of the method. Poor reproducibility may also be caused
by hypoxia during the operation or variations in the fixation
(Cross et al., 1990). By using a standardised method like the
M/V index, the interobserver variation in the mitosis
counting can be partly controlled (Haapasalo et al., 1989;
Lipponen et al., 1990). However, the area ofmitosis counting
is usually chosen subjectively by the observer and can thus be
a source ofuncontrolled variation between the measurements.
To conclude, the accuracy ofTNM classification in gastric
cancer could be improved, if vascular, lymphatic, perineural
and submucosal invasion as well as the density of the
lymphoplasmacytic infiltration are assessed. This information
is easily obtained in connection with routine histological
examination without any special or laborious techniques.
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